Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. gender-cf

GENDER-CF

Gender-related differences in expression of microRNAs in cystic fibrosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 GENDER-CF project word cloud

Explore the words cloud of the GENDER-CF project. It provides you a very rough idea of what is the project "GENDER-CF" about.

centre    respiratory    rcsi    flow    supervision    data    fibrosis    regulation    host    immunity    germany    independence    netherlands    airway    team    innovative    altered    hormone    patients    career    form    expertise    inflammatory    infective    transferable    encoding    competencies    laboratory    channel    fellowship    tlr4    pi    skills    college    disadvantage    position    am    secondments    university    gap    teams    inflammation    leiden    expression    cystic    mirnas    death    heidelberg    epithelial    network    ion    renowned    consequent    hereditary    function    cornerstone    acquisition    public    progression    cf    applicable    female    exacerbations    estrogen    toll    implicated    world    progressive    ing    keen    mirna    disease    morbidity    genes    equipped    royal    tumour    statistically    survival    qpcr    therapies    ongoing    cell    professionally    active    collaborative    microrna    accelerating    predicted    surgeons    strengthen    traf6    combine    richly    aid    medical    class    diversify    cytometry    ireland    mediators    gender    lung    engagement    necrosis    immunology    expand    noted    innate    student    females    sex    pulmonary    defective    plays    receptor   

Project "GENDER-CF" data sheet

The following table provides information about the project.

Coordinator		 ROYAL COLLEGE OF SURGEONS IN IRELAND 

Organization address
address: Saint Stephen's Green 123
city: DUBLIN
postcode: 2
website: www.rcsi.ie

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Ireland [IE]
 Project website https://www.researchgate.net/project/Gender-related-differences-in-expression-of-microRNAs-in-cystic-fibrosis
 Total cost 175˙866 €
 EC max contribution 175˙866 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-09-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ROYAL COLLEGE OF SURGEONS IN IRELAND IE (DUBLIN) coordinator 175˙866.00

Map

 Project objective

Cystic fibrosis (CF) is a hereditary disease involving a defective ion channel, resulting in altered epithelial cell function and consequent infective/inflammatory airway exacerbations. Progressive loss of lung function is the leading cause of death in CF patients. It is statistically noted that females have a disadvantage in survival and morbidity; this is commonly referred to as the CF gender gap. Recent studies have implicated the female sex hormone, estrogen, in this gender gap. CF patients show altered microRNA expression and some of the affected miRNAs are predicted to target genes encoding key inflammatory mediators such as Toll-like receptor 4 (TLR4) and tumour necrosis factor a receptor associated factor-6 (TRAF6). This highly innovative proposal, to be implemented at the Royal College of Surgeons Ireland (RCSI), aims to study the regulation of key miRNAs by estrogen and investigate if this plays a role in the CF gender gap. I will combine my own expertise in pulmonary innate immunity with the host PI’s world-class knowledge of CF and miRNA research. The research will further our understanding of inflammation in CF to aid development of better therapies. I will develop professionally as I: a) diversify my competencies through the acquisition of new laboratory skills (e.g. qPCR, flow cytometry), b) strengthen my transferable skills (e.g. project management, public engagement, data dissemination) and c) expand my collaborative network through secondments to other world-renowned research teams in Leiden University Medical Centre, Netherlands and University of Heidelberg, Germany. I will contribute richly to research at RCSI as I am already equipped with skills applicable to ongoing work in the team and am keen to take an active role in student supervision. The opportunities carried by this fellowship will form the cornerstone of my career, accelerating my progression towards my goal of achieving a position of independence in respiratory immunology research.

 Publications

year authors and title journal last update
List of publications.
2018 Arlene M.A. Glasgow, Chiara De Santi, Catherine M. Greene
Non-coding RNA in cystic fibrosis
published pages: 619-630, ISSN: 0300-5127, DOI: 10.1042/bst20170469 		Biochemical Society Transactions 46/3 2020-01-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GENDER-CF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GENDER-CF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Widow Spider Mating (2020)

Immature mating as a novel tactic of an invasive widow spider

Read More  

CP-FTmmW Aminogen (2020)

Chemistry and structure of aminogen radicals using chirped-pulse Fourier transform (sub)millimeter rotational spectroscopy

Read More  

TARGET SLEEP (2020)

Boosting motor learning through sleep and targeted memory reactivation in ageing and Parkinson’s disease

Read More